These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21708519)

  • 1. Beneficial effects of pseudoceramide-containing physiologic lipid mixture as a vehicle for topical steroids.
    Lee YB; Park HJ; Kwon MJ; Jeong SK; Cho SH
    Eur J Dermatol; 2011; 21(5):710-6. PubMed ID: 21708519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudoceramide stimulates peroxisome proliferator-activated receptor-α expression in a murine model of atopic dermatitis: molecular basis underlying the anti-inflammatory effect and the preventive effect against steroid-induced barrier impairment.
    Lee SE; Jung MK; Oh SJ; Jeong SK; Lee SH
    Arch Dermatol Res; 2015 Nov; 307(9):781-92. PubMed ID: 26121942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olopatadine hydrochloride accelerates the recovery of skin barrier function in mice.
    Amano T; Takeda T; Yano H; Tamura T
    Br J Dermatol; 2007 May; 156(5):906-12. PubMed ID: 17355233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin.
    Man MQ; Feingold KR; Elias PM
    Arch Dermatol; 1993 Jun; 129(6):728-38. PubMed ID: 8507075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a multilamellar emulsion on glucocorticoid-induced epidermal atrophy and barrier impairment.
    Ahn SK; Bak HN; Park BD; Kim YH; Youm JK; Choi EH; Hong SP; Lee SH
    J Dermatol; 2006 Feb; 33(2):80-90. PubMed ID: 16556273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities.
    Kao JS; Fluhr JW; Man MQ; Fowler AJ; Hachem JP; Crumrine D; Ahn SK; Brown BE; Elias PM; Feingold KR
    J Invest Dermatol; 2003 Mar; 120(3):456-64. PubMed ID: 12603860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of topical corticosteroid and tacrolimus on ceramides and irritancy to sodium lauryl sulphate in healthy skin.
    Jungersted JM; Høgh JK; Hellegren LI; Jemec GB; Agner T
    Acta Derm Venereol; 2011 May; 91(3):290-4. PubMed ID: 21365172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study to assess the occlusivity and moisturization potential of three topical corticosteroid products using the skin trauma after razor shaving (STARS) bioassay.
    Kircik LH
    J Drugs Dermatol; 2014 May; 13(5):582-5. PubMed ID: 24809882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of an atopic dermatitis-like skin model in a hairless mouse by repeated elicitation of contact hypersensitivity that enables to conduct functional analyses of the stratum corneum with various non-invasive biophysical instruments.
    Matsumoto K; Mizukoshi K; Oyobikawa M; Ohshima H; Tagami H
    Skin Res Technol; 2004 May; 10(2):122-9. PubMed ID: 15059180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis.
    Jensen JM; Pfeiffer S; Witt M; Bräutigam M; Neumann C; Weichenthal M; Schwarz T; Fölster-Holst R; Proksch E
    J Allergy Clin Immunol; 2009 May; 123(5):1124-33. PubMed ID: 19410693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical glucocorticoid or pimecrolimus treatment suppresses thymic stromal lymphopoietin-related allergic inflammatory mechanism in an oxazolone-induced atopic dermatitis murine model.
    Yoon NY; Jung My; Kim DH; Lee HJ; Choi EH
    Arch Dermatol Res; 2015 Sep; 307(7):569-81. PubMed ID: 25786383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The characterization of molecular organization of multilamellar emulsions containing pseudoceramide and type III synthetic ceramide.
    Park BD; Youm JK; Jeong SK; Choi EH; Ahn SK; Lee SH
    J Invest Dermatol; 2003 Oct; 121(4):794-801. PubMed ID: 14632198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudoceramide-containing physiological lipid mixture reduces adverse effects of topical steroids.
    Kim HJ; Park HJ; Yun JN; Jeong SK; Ahn SK; Lee SH
    Allergy Asthma Immunol Res; 2011 Apr; 3(2):96-102. PubMed ID: 21461248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal ratios of topical stratum corneum lipids improve barrier recovery in chronologically aged skin.
    Zettersten EM; Ghadially R; Feingold KR; Crumrine D; Elias PM
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):403-8. PubMed ID: 9308554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A look at epidermal barrier function in atopic dermatitis: physiologic lipid replacement and the role of ceramides.
    Sajić D; Asiniwasis R; Skotnicki-Grant S
    Skin Therapy Lett; 2012 Jul; 17(7):6-9. PubMed ID: 22825649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new moisturizer containing physiologic lipid granules alleviates atopic dermatitis.
    Na JI; Hwang JS; Park HJ; Kim DH; Park WS; Youn SW; Huh CH; Park KC
    J Dermatolog Treat; 2010 Jan; 21(1):23-7. PubMed ID: 19626524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous effect of ursolic acid and oleanolic acid on epidermal permeability barrier function and epidermal keratinocyte differentiation via peroxisome proliferator-activated receptor-alpha.
    Lim SW; Hong SP; Jeong SW; Kim B; Bak H; Ryoo HC; Lee SH; Ahn SK
    J Dermatol; 2007 Sep; 34(9):625-34. PubMed ID: 17727365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moisturizers versus Current and Next-Generation Barrier Repair Therapy for the Management of Atopic Dermatitis.
    Elias PM; Wakefield JS; Man MQ
    Skin Pharmacol Physiol; 2019; 32(1):1-7. PubMed ID: 30336483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Objective evaluation of the efficacy of daily topical applications of cosmetics bases using the hairless mouse model of atopic dermatitis.
    Matsumoto K; Mizukoshi K; Oyobikawa M; Ohshima H; Sakai Y; Tagami H
    Skin Res Technol; 2005 Aug; 11(3):209-17. PubMed ID: 15998334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function.
    Kim M; Jung M; Hong SP; Jeon H; Kim MJ; Cho MY; Lee SH; Man MQ; Elias PM; Choi EH
    Exp Dermatol; 2010 Jun; 19(6):501-10. PubMed ID: 19703225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.